Objective: To determine cut-off values of BASDAI that can discriminate the four disease activity states (inactive disease, moderate disease activity, high disease activity and very high disease activity), separated by the validated Ankylosing Spondylitis Disease Activity Score (ASDAS) cut-off values (1.3, 2.1 and 3.5). Methods: We included 333 patients with axial SpA whose data on BASDAI and ASDAS-CRP were available. Receiver operating characteristic curve analysis was performed to determine the BASDAI cut-off values that best corresponded to ASDAS-CRP cut-off values. The degree of agreement between disease activity states based on the BASDAI and ASDAS-CRP cut-off values was assessed using weighted kappa. Results: Of the total 333 patient...
Purpose of review The evaluation of disease activity in axial spondyloarthritis (SpA) is complex and...
<p>Scatterplots of healthy control versus axial spondyloarthritis (aSpA) difference scores and disea...
Introduction In a previous phase, 12 draft definitions for clinically important worsening in axial s...
Background The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to ass...
Objectives: To evaluate various validity aspects of four disease activity scores (ASDAS) for ankylos...
The aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Ac...
Various types of disease activity measures are available for axial spondyloarthritis (axSpA), and th...
To develop a new equation to calculate the Ankylosing Spondylitis Disease Activity Score based on CR...
The aim of this study was to assess discriminant validity of Ankylosing Spondylitis Disease Activity...
Objective. To establish cutoffs for the minimum clinically important improvement (MCII) and the pati...
To develop a new index for disease activity in ankylosing spondylitis (ASDAS) that is truthful, disc...
Background: The Ankylosing Spondylitis (AS) Disease Activity Score (ASDAS) is largely used for asses...
Objective. To develop an alternative Ankylosing Spondylitis Disease Activity Score (ASDAS) to be use...
Objective. To evaluate the validity of different ASDAS sets to assess disease activity in ankylosing...
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional ...
Purpose of review The evaluation of disease activity in axial spondyloarthritis (SpA) is complex and...
<p>Scatterplots of healthy control versus axial spondyloarthritis (aSpA) difference scores and disea...
Introduction In a previous phase, 12 draft definitions for clinically important worsening in axial s...
Background The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to ass...
Objectives: To evaluate various validity aspects of four disease activity scores (ASDAS) for ankylos...
The aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Ac...
Various types of disease activity measures are available for axial spondyloarthritis (axSpA), and th...
To develop a new equation to calculate the Ankylosing Spondylitis Disease Activity Score based on CR...
The aim of this study was to assess discriminant validity of Ankylosing Spondylitis Disease Activity...
Objective. To establish cutoffs for the minimum clinically important improvement (MCII) and the pati...
To develop a new index for disease activity in ankylosing spondylitis (ASDAS) that is truthful, disc...
Background: The Ankylosing Spondylitis (AS) Disease Activity Score (ASDAS) is largely used for asses...
Objective. To develop an alternative Ankylosing Spondylitis Disease Activity Score (ASDAS) to be use...
Objective. To evaluate the validity of different ASDAS sets to assess disease activity in ankylosing...
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional ...
Purpose of review The evaluation of disease activity in axial spondyloarthritis (SpA) is complex and...
<p>Scatterplots of healthy control versus axial spondyloarthritis (aSpA) difference scores and disea...
Introduction In a previous phase, 12 draft definitions for clinically important worsening in axial s...